Precious metals have taken a recent hit in global markets.However, many of the junior gold mining companies continue to forge ahead with their operations, capitalizing on the momentum built up since the beginning of the year. One of these miners which is capturing the attention of investors is Brazil Resources.
Brazil Resources is a junior gold mining company with a large collection of prospective properties, currently trading under the symbol BRI on the TSX Venture Exchange. Six of its projects already have an NI 43-101 resource estimate. The Company also has a prospective uranium property in the Athabasca Basin, a project in which it is presently engaged in a joint venture with Areva Resources Canada Inc. Brazil Resources is led by Amir Adnani, the Company’s Chairman and Founder. Adnani is an esteemed entrepreneur, frequently invited for speaking engagements, and was named by Fortune Magazine on its “40 under 40, Ones to Watch” list.
Please have a listen to this podcast, and find out more about this exciting story...
Mines and Money Americas was a fantastic success as the globally recognized industry event made its way to the Americas, more specifically Toronto, for the first time in the 13 years the event has been going on. Dr. Kal Kotecha attended this year's milestone conference and had an opportunity to sit down with Doug MacQuarrie, CEO at Asante Gold (CSE:ASE), to get a closer view at the company, its portfolio and future prospects. Have a listen.
Mines and Money Americas was a fantastic success as the globally recognized industry event made its way to the Americas, more specifically Toronto, for the first time in the 13 years the event has been going on. Dr. Kal Kotecha attended this year's milestone conference and had an opportunity to sit down with David Morgan of the Morgan Report, to get a closer view at the mining sector and more specifically the precious metals market. Have a listen.
The enormous potential of green energy revolution has made lithium one of the most important minerals of the 21st century. Neo Lithium (TSX: V.NLC) is an interesting mining junior with an exciting story and a high-grade, low-impurity salar and brine reservoir complex in the fabled Lithium Triangle of Argentina. Investors clamored to be part of the action when the company went public at the end of July. In fact, shares in Neo Lithium rose 357% to $1.60 per share by the afternoon of its first day and its valuation has remained relatively strong ever since. Vancouver-based mining journalist, Marc Davis, acting on behalf of Stockhouse Publishing, sat with Dr. Waldo Perez, President and CEO of Neo Lithium, to find out what the company and the lithium market mean to you, the investor. Have a listen.
Orefinders Resources (TSX: V.ORX) has put together a robust property portfolio in two of Canada’s most prolific gold districts. Its wholly-owned flagship Mirado project, located 35 kilometres southeast of the gold mining town of Kirkland Lake, Ontario, encompasses 5,800 acres and plays host to three former producing mines. Unlike many exploration and development companies, Orefinders leverages near-term cash-flow potential with the Mirado Stockpile Project. It was because of this that Gaalen Engen, Head of Editorial for Stockhouse Publishing, spoke with Orefinders Resources CEO & Director, Stephen Stewart, to get a deep-dive perspective on the company, its portfolio and just what Orefinders' innovative development plan means to the investment community. Have a listen.
As
we move forward into the 21st century with alternative energy
travelling on smart grids servicing a variety of energy storage systems, PGMs
will become ever more integral to our daily life. The need for large domestic
supplies will also become incredibly important as the world continues to define
its geo-political boundaries. It’s no wonder North American juniors are scrambling to put
together the next big domestic PGM find. Pacific North West Capital (TSX: V.PFN) has built a robust
and diverse portfolio of properties, which includes the company’s 100%-owned
highly-prospective River Valley PGM project located in Northern Ontario. Stockhouse's own Gaalen Engen, speaks with Harry Barr, Chairman, CEO & Director of Pacific North West Capital, to
get a closer look at the company, its assets and the potential it holds for
investors. Have a listen.
Early detection has always been key in cancer treatment. In a global cancer/tumor profiling market expected to hit $35 billion by 2018, there is a company, Biomark Diagnostics (CSE: BUX), which is developing a diagnostic technique that will identify the presence of cancer earlier than any method to date while the tumor is pre-visible and pre-symptomatic. This means the patient can look forward to significantly greater successful treatment outcomes. Hi, I’m Gaalen Engen, Head of Editorial for Stockhouse Publishing, and I spoke with Biomark Diagnostics founder and CEO, Rashid Ahmed, to get a better idea of the company and its tremendous potential to disrupt a multi-billion medical market. Have a listen.
Brazil Resources (TSX: V.BRI), a Vancouver-based
exploration and development play, has put together a very interesting portfolio
of advanced-stage gold assets in both North and South America. While other
juniors fade and throw in the towel, Brazil Resources’ business strategy has
leveraged the current sector downturn to shrewdly capitalize on some highly
prospective acquisition opportunities involving both property and equipment,
placing it in prime position to take advantage of gold’s inevitable recovery. Hi, I'm Gaalen Engen, Head of Editorial at Stockhouse Publishing. I spoke with Brazil Resources Chairman and founder, Amir Adnani, to get a deep
dive look at the opportunity Brazil Resources presents for investors. Have a
listen.
Lattice Biologics (TSX: V.LBL) is a biotech venture working in the field of cellular therapies and tissue engineering with a focus on bone, skin and cartilage regeneration. Its Extracelluar Matrix Technology has made Lattice an emerging leader in the sector as it develops and processes biologic allograft products for both domestic and international markets. More recently the company has expanded its portfolio and through the use of its ECM technology is developing a disruptive cancer diagnostic technique that is sure to revolutionize the way oncologists treat their patients. I’m Gaalen Engen, head of Editorial at Stockhouse Publishing, have a listen as I speak with Lattice Biologics CEO, Guy Cook, to get a better understanding of the company and the potential it holds.
